Published in Lancet on October 31, 1998
Alternative ankle-brachial index method identifies additional at-risk individuals. J Am Coll Cardiol (2013) 1.86
The exclusion of patients with chronic kidney disease from clinical trials in coronary artery disease. Kidney Int (2006) 1.47
Quality of life after PCI vs CABG among patients with diabetes and multivessel coronary artery disease: a randomized clinical trial. JAMA (2013) 1.01
Cardiac revascularization--a need for independent decision-makers. J R Soc Med (2005) 0.96
Is there an additional benefit from coronary revascularization in diabetic patients with acute coronary syndromes or stable angina who are already on optimal medical treatment? Arch Med Sci (2011) 0.94
One year comparison of costs of coronary surgery versus percutaneous coronary intervention in the stent or surgery trial. Heart (2004) 0.92
Coronary revascularization in diabetic patients: Current state of evidence. Exp Clin Cardiol (2011) 0.87
Reduced risk of myocardial infarct and revascularization following coronary artery bypass grafting compared with percutaneous coronary intervention in patients with chronic kidney disease. Kidney Int (2016) 0.84
The role of invasive therapies in elderly patients with acute myocardial infarction. Clinics (Sao Paulo) (2009) 0.82
Comparison of percutaneous coronary intervention with drug eluting stents versus coronary artery bypass grafting in patients with multivessel coronary artery disease: Meta-analysis of six randomized controlled trials. Cardiovasc Revasc Med (2015) 0.81
Comparative effectiveness of coronary artery bypass grafting and percutaneous coronary intervention for multivessel coronary disease in a community-based population with chronic kidney disease. Am Heart J (2013) 0.81
Revascularization treatment in patients with coronary artery disease. Hippokratia (2008) 0.80
Short, Intermediate and long term outcomes of CABG vs. PCI with DES in Patients With Multivessel Coronary Artery Disease. Meta-Analysis of Six Randomized Controlled Trials. Eur J Cardiovasc Med (2014) 0.79
Debate: PCI vs CABG: a moving target, but we are gaining. Curr Control Trials Cardiovasc Med (2001) 0.78
Outcomes of revascularization strategies for two-vessel coronary artery disease involving the proximal left anterior descending artery in an era of improved pharmacotherapy and stenting. Can J Cardiol (2008) 0.78
Description of a Heart Team approach to coronary revascularization and its beneficial long-term effect on clinical events after PCI. Clin Res Cardiol (2015) 0.76
Impact of invasive treatment strategy on health-related quality of life six months after non-ST-elevation acute coronary syndrome. J Geriatr Cardiol (2014) 0.76
Percutaneous coronary intervention in diabetics: time to consider "intimal remodelling therapy"? Heart (2002) 0.75
Long-term results of RITA-1. Lancet (1999) 0.75
Combination and triple therapy in patients with stable angina pectoris not adequately controlled by optimal β-blocker therapy. Neth Heart J (2002) 0.75
An Atelocollagen Coating for Efficient Local Gene Silencing by Using Small Interfering RNA. Mol Ther Nucleic Acids (2017) 0.75
Sequential treatment assignment with balancing for prognostic factors in the controlled clinical trial. Biometrics (1975) 18.25
British Regional Heart Study: cardiovascular risk factors in middle-aged men in 24 towns. Br Med J (Clin Res Ed) (1981) 14.25
Efficient neutralization of primary isolates of HIV-1 by a recombinant human monoclonal antibody. Science (1994) 13.54
Sexual behaviour in Britain: partnerships, practices, and HIV risk behaviours. Lancet (2001) 13.31
Statistical guidelines for contributors to medical journals. Br Med J (Clin Res Ed) (1983) 10.90
Trial of tissue plasminogen activator for mortality reduction in acute myocardial infarction. Anglo-Scandinavian Study of Early Thrombolysis (ASSET). Lancet (1988) 10.64
The Multicentre Aneurysm Screening Study (MASS) into the effect of abdominal aortic aneurysm screening on mortality in men: a randomised controlled trial. Lancet (2002) 10.52
Subgroup analysis and other (mis)uses of baseline data in clinical trials. Lancet (2000) 9.80
Sexual behaviour in Britain: reported sexually transmitted infections and prevalent genital Chlamydia trachomatis infection. Lancet (2001) 9.75
Explaining heterogeneity in meta-analysis: a comparison of methods. Stat Med (1999) 9.40
Evaluating patient-based outcome measures for use in clinical trials. Health Technol Assess (1998) 9.32
Relative contributions of history-taking, physical examination, and laboratory investigation to diagnosis and management of medical outpatients. Br Med J (1975) 9.18
Maternal serum screening for Down's syndrome in early pregnancy. BMJ (1988) 8.65
Statistical problems in the reporting of clinical trials. A survey of three medical journals. N Engl J Med (1987) 8.64
Sexual behaviour in Britain: early heterosexual experience. Lancet (2001) 7.62
Repeated measures in clinical trials: analysis using mean summary statistics and its implications for design. Stat Med (1992) 7.33
The end of clinical freedom. Br Med J (Clin Res Ed) (1983) 6.27
Inhaled zanamivir for the prevention of influenza in families. Zanamivir Family Study Group. N Engl J Med (2000) 5.98
British Regional Heart Study: geographic variations in cardiovascular mortality, and the role of water quality. Br Med J (1980) 5.56
Risk factors for ischaemic heart disease: the prospective phase of the British Regional Heart Study. J Epidemiol Community Health (1985) 5.53
Maternal vitamin D intake and mineral metabolism in mothers and their newborn infants. Br Med J (1980) 4.97
A clinical trial comparing three antithrombotic-drug regimens after coronary-artery stenting. Stent Anticoagulation Restenosis Study Investigators. N Engl J Med (1998) 4.68
Meta-analysis of randomised trials comparing coronary angioplasty with bypass surgery. Lancet (1995) 4.65
Randomized trials or observational tribulations? N Engl J Med (2000) 4.49
Evidence of inadequate investigation and treatment of patients with heart failure. Br Heart J (1994) 4.40
A randomised trial of home-versus-hospital management for patients with suspected myocardial infarction. Lancet (1978) 4.12
Social class differences in ischaemic heart disease in British men. Lancet (1987) 4.09
Diagnosis and treatment of coronary disease: comparison of doctors' attitudes in the USA and the UK. Lancet (1988) 4.07
Does breathing other people's tobacco smoke cause lung cancer? Br Med J (Clin Res Ed) (1986) 4.06
Prevalence of angina as assessed by a survey of prescriptions for nitrates. Lancet (1988) 4.01
Cost-benefit analysis of long-term haemodialysis for chronic renal failure. Br Med J (1975) 3.87
Identifying men at high risk of heart attacks: strategy for use in general practice. Br Med J (Clin Res Ed) (1986) 3.76
Impact of hospital thrombolysis policy on out-of-hospital response to suspected myocardial infarction. Lancet (1993) 3.43
Can meta-analyses be trusted? Lancet (1991) 3.43
Modelling in economic evaluation: an unavoidable fact of life. Health Econ (1997) 3.40
Structure and transcription of eukaryotic tRNA genes. CRC Crit Rev Biochem (1985) 3.38
Social inequality in coronary risk: central obesity and the metabolic syndrome. Evidence from the Whitehall II study. Diabetologia (1997) 3.34
Cost effectiveness of screening for and eradication of Helicobacter pylori in management of dyspeptic patients under 45 years of age. BMJ (1996) 3.33
Long-term survival of patients with breast cancer: a study of the curability of the disease. Br Med J (1979) 3.29
Randomised controlled trial of laparoscopic versus open mesh repair for inguinal hernia: outcome and cost. BMJ (1998) 3.26
Variations in GP night visiting rates: medical organisation and consumer demand. Br Med J (1977) 3.24
Childhood obesity and adult cardiovascular mortality: a 57-y follow-up study based on the Boyd Orr cohort. Am J Clin Nutr (1998) 3.21
Audit of coronary angiography and bypass surgery. Lancet (1990) 3.17
An epidemiological study of workers producing enzyme washing powders. Lancet (1970) 2.98
Childhood leg length and adult mortality: follow up of the Carnegie (Boyd Orr) Survey of Diet and Health in Pre-war Britain. J Epidemiol Community Health (1998) 2.95
Renal function, neurohormonal activation, and survival in patients with chronic heart failure. Circulation (2000) 2.90
Open access. BMJ (1995) 2.76
Screening for treatable diabetic retinopathy: a comparison of different methods. Diabet Med (1991) 2.76
Comparison of results from a cardiac ambulance manned by medical or non-medical personnel. Lancet (1977) 2.75
Effects of alteplase in acute myocardial infarction: 6-month results from the ASSET study. Anglo-Scandinavian Study of Early Thrombolysis. Lancet (1990) 2.70
Do women with acute myocardial infarction receive the same treatment as men? BMJ (1994) 2.70
Follow-up of emergency ambulance calls in Nottingham: implications for coronary ambulance servie. Br Med J (1975) 2.66
Maternal serum unconjugated oestriol as an antenatal screening test for Down's syndrome. Br J Obstet Gynaecol (1988) 2.62
A scoring system to identify men at high risk of a heart attack. Health Trends (1987) 2.58
Final follow-up of the Multicentre Aneurysm Screening Study (MASS) randomized trial of abdominal aortic aneurysm screening. Br J Surg (2012) 2.55
Trial of early nifedipine in acute myocardial infarction: the Trent study. Br Med J (Clin Res Ed) (1986) 2.55
Randomised placebo-controlled trial comparing oxprenolol with disopyramide phosphate in immediate treatment of suspected myocardial infarction. Lancet (1980) 2.53
Management of myocardial infarction: implications for current policy derived from the Nottingham Heart Attack Register. Br Heart J (1992) 2.46
Risk factors for stroke in middle aged British men. BMJ (1991) 2.44
Investigating underlying risk as a source of heterogeneity in meta-analysis. Stat Med (1997) 2.43
Significance of smoking in patients receiving thrombolytic therapy for acute myocardial infarction. Experience gleaned from the International Tissue Plasminogen Activator/Streptokinase Mortality Trial. Circulation (1993) 2.42
Birth prevalence of Down's syndrome in England and Wales. Prenat Diagn (1991) 2.39
Randomised trial of a mobile coronary care unit for emergency calls. Br Med J (1978) 2.35
Randomised trial comparing propranolol with atenolol in immediate treatment of suspected myocardial infarction. Br Med J (1980) 2.32
Prognosis of patients with "chest pain ?cause". Br Med J (Clin Res Ed) (1981) 2.32
Quality of life four years after acute myocardial infarction: short form 36 scores compared with a normal population. Heart (1999) 2.31
Lead exposure and children's intellectual performance. Int J Epidemiol (1987) 2.30
Regression of area mortality rates on explanatory variables: what weighting is appropriate? J R Stat Soc Ser C Appl Stat (1981) 2.26
The episode-free day as a composite measure of effectiveness: an illustrative economic evaluation of formoterol versus salbutamol in asthma therapy. Pharmacoeconomics (1993) 2.26
Giving up smoking and the risk of heart attacks. A report from The British Regional Heart Study. Lancet (1986) 2.19
5-year outcome of an interventional strategy in non-ST-elevation acute coronary syndrome: the British Heart Foundation RITA 3 randomised trial. Lancet (2005) 2.15
Allocation of patients to treatment in clinical trials. Biometrics (1979) 2.13
On the design and analysis of randomized clinical trials with multiple endpoints. Biometrics (1993) 2.13
Early reporting of myocardial infarction: impact of an experiment in patient education. Br Med J (Clin Res Ed) (1982) 2.11
Inpatient deaths from acute myocardial infarction, 1982-92: analysis of data in the Nottingham heart attack register. BMJ (1997) 2.08
Mode of referral to hospital of patients with heart attacks: relevance to home care and special ambulance services. Br Med J (1976) 2.04
Assessment of methods for estimating autonomic nervous control of the heart in patients with diabetes mellitus. Diabetes (1978) 2.04
Short-term effects of air pollution on daily mortality in Athens: a time-series analysis. Int J Epidemiol (1994) 2.03
Effects of alcohol and smoking on blood lead in middle-aged British men. Br Med J (Clin Res Ed) (1982) 2.03
The combination of randomized and historical controls in clinical trials. J Chronic Dis (1976) 2.00
Issues in data monitoring and interim analysis of trials. Health Technol Assess (2005) 1.96
Association of C-reactive protein with type 2 diabetes: prospective analysis and meta-analysis. Diabetologia (2009) 1.96
Prevention of mother-to-child transmission of HIV-1 infection: alternative strategies and their cost-effectiveness. AIDS (1998) 1.94
Consumption of sweet beverages and type 2 diabetes incidence in European adults: results from EPIC-InterAct. Diabetologia (2013) 1.93
Advanced training for ambulance crews: implications from 403 consecutive patients with cardiac arrest managed by crews with simple training. Br Med J (Clin Res Ed) (1987) 1.92
Acute myocardial infarction in the young--the role of smoking. The Investigators of the International Tissue Plasminogen Activator/Streptokinase Mortality Trial. Eur Heart J (1995) 1.90
Effects of 22 months of treatment with inhaled corticosteroids and/or beta-2-agonists on lung function, airway responsiveness, and symptoms in children with asthma. The Dutch Chronic Non-specific Lung Disease Study Group. Am Rev Respir Dis (1992) 1.89
Quality of life, employment status, and anginal symptoms after coronary angioplasty or bypass surgery. 3-year follow-up in the Randomized Intervention Treatment of Angina (RITA) Trial. Circulation (1996) 1.86
Presentation and analysis of the results of clinical trials in cardiovascular disease. Br Med J (Clin Res Ed) (1981) 1.86
Effect of prostaglandin E1 on platelet behaviour in vitro and in vivo. Br Med J (1967) 1.85
Biochemical and haematological response to alcohol intake. Ann Clin Biochem (1985) 1.84
Diagnostic criteria for myocardial infarction. Br J Hosp Med (1981) 1.82
Correlation of the leptin:adiponectin ratio with measures of insulin resistance in non-diabetic individuals. Diabetologia (2009) 1.81
Cost effectiveness of clinically appropriate decisions on alternative treatments for angina pectoris: prospective observational study. BMJ (2007) 1.81
British blood cholesterol values and the American consensus. Br Med J (Clin Res Ed) (1985) 1.80
The effect of lorcainide on arrhythmias and survival in patients with acute myocardial infarction: an example of publication bias. Int J Cardiol (1993) 1.80
Blood pressure and hypertension in middle-aged British men. J Hypertens (1988) 1.80